Deryk Jones, MD
Sports Medicine · San Carlos, CANPI 1356390611
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (44.9%), other and speaking fees — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Linvatec Corporation at 35.7% of the total. Among sports medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 542 payments — averaging $1689.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Linvatec Corporation$327K
- Vericel Corporation$281K
- Medical Device Business Services, Inc.$167K
- Musculoskeletal Transplant Foundation Inc.$37K
- Pacira Therapeutics, Inc.$32K
- Biorez, Inc.$25K
- plus $47K from 29 others
Across 155 payments — averaging $5050.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Linvatec Corporation$176K
- Endo Pharmaceuticals Inc.$155K
- Biotissue Holdings Inc.$107K
- Smith+Nephew$88K
- Vericel Corporation$79K
- Miach Orthopaedics, Inc.$59K
- plus $119K from 5 others
Across 1 payment — averaging $31,248 each. An ownership or investment interest held by the physician or an immediate family member.
- Overture Orthopaedics$31K
What the payments were for
- Consulting fees$411,20645%
- Speaking & faculty fees$181,80020%
- Grants$38,9974%
- Travel & lodging$56,5536%
- Food & beverage$17,9152%
- Education$1,2000%
- Entertainment$190%
- Other$207,80923%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Linvatec Corporation | 93 | $327,131 |
| Vericel Corporation | 194 | $281,218 |
| Medical Device Business Services, Inc. | 81 | $166,597 |
| Musculoskeletal Transplant Foundation Inc. | 29 | $36,851 |
| Pacira Therapeutics, Inc. | 34 | $31,863 |
| Biorez, Inc. | 5 | $24,714 |
| Amniox Medical, Inc. | 7 | $17,499 |
| Acumed LLC | 10 | $11,770 |
| Depuy Synthes Products, Inc. | 4 | $7,750 |
| ALON Medical Technology | 5 | $2,082 |
| Arthrex | 14 | $1,245 |
| Stryker | 11 | $968 |
| Johnson & Johnson | 7 | $789 |
| Joint Restoration Foundation, Inc. | 4 | $548 |
| Aesculap Biologics, LLC | 5 | $516 |
| Biotissue Holdings Inc. | 2 | $425 |
| Smith+Nephew | 5 | $403 |
| Newclip USA LLC | 2 | $380 |
| Restor3d, Inc. | 2 | $293 |
| Anika Therapeutics, Inc. | 2 | $284 |
| Miach Orthopaedics, Inc. | 3 | $265 |
| Bioventus LLC | 3 | $263 |
| Pacira Pharmaceuticals Incorporated | 3 | $255 |
| Orthalign Inc | 2 | $254 |
| Ossur Americas, Inc. | 3 | $230 |
| Overture Orthopaedics | 2 | $160 |
| Arthrosurface Incorporated | 1 | $116 |
| Mallinckrodt Hospital Products Inc. | 1 | $114 |
| Zimmer Biomet | 1 | $109 |
| Medtronic | 1 | $95 |
| DJO, LLC | 1 | $87 |
| Conmed Corporation | 1 | $83 |
| Conformis, Inc. | 2 | $77 |
| Sanofi-aventis U.S. LLC | 1 | $45 |
| Vertex | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BioBrace 23mm$316,842
- MACI$256,643
- INTRAFIX$113,129
- ORTHOCORD$113,129
- CAPITAL EQUIPMENT CART$78,502
- HEALIX$78,502
- ATTUNE$50,131
- GLOBAL$48,667
- RECLAIM$48,667
- HEALIX KNOTLESS PEEK$35,013
- N/A$34,627
- Zilretta$31,582
- SIGMA$25,602
- BioBrace 5mm$24,668
- TC3$23,064
- LINVATEC KNEE PRESERVATION SYSTEM$18,688
- NEOX$17,499
- CLARIX$17,499
- KNEE BIOLOGICS$10,024
- ALLOGRAFT TISSUE$5,383
How this compares
$915,499 in reported general payments places this provider in the 95th percentile of 662 sports medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 114 | $2,430 |
| Methocarbamol | 36 | $422 |
| Pregabalin | 28 | $246 |
| Meloxicam | 62 | $199 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $151 |
| Gabapentin | 17 | $106 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in San Carlos
- Neal ElattracheLos Angeles$51M
- Nathaniel CohenLos Gatos$6.4M
- Thomas KnappSanta Monica$2.5M
- Michael FreehillStanford$1.6M
- Allan MishraMenlo Park$1.5M
- Heinz Hoeneckela Jolla$1.4M
- Seth ShermanStanford$1.1M
- Stephan YacoubianBurbank$1M
- Stephen Snydervan Nuys$922K
- Scott GrahamLaguna Woods$878K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.